Literaturverzeichnis

Ahima, R. S. und Flier, J. S. (2000): Adipose tissue as an endocrine organ, Trends Endocrinol Metab 11 [8], Seite 327-332.

Albiston, A. L.; McDowall, S. G.; Matsacos, D.; Sim, P.; Clune, E.; Mustafa, T.; Lee, J.; Mendelsohn, F. A.; Simpson, R. J.; Connolly, L. M. und Chai, S. Y. (2001): Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase, J Biol Chem. 276 [52], Seite 48623-48626.

Allison, D. B.; Fontaine, K. R.; Manson, J. E.; Stevens, J. und VanItallie, T. B. (1999): Annual deaths attributable to obesity in the United States, JAMA 282 [16], Seite 1530-1538.

Alzheimer, Alois (1906): Über eine eigenartige Erkrankung der Hirnrinde, Zentralblatt für Nervenheilkunde und Psychiatrie 30, Seite 177-179.

Arnal, J. F.; Castano, C.; Maupas, E.; Mugniot, A.; Darblade, B.; Gourdy, P.; Michel, J. B. und Bayard, F. (2001b): Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice, Atherosclerosis 155 [2], Seite 291-295.

Atwood, C. S.; Moir, R. D.; Huang, X.; Scarpa, R. C.; Bacarra, N. M.; Romano, D. M.; Hartshorn, M. A.; Tanzi, R. E. und Bush, A. I. (1998): Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis, J Biol Chem. 273 [21], Seite 12817-12826.

Aust, L; Dongowski, G; Frenz, U; Täufel, A und Noack, R (2001): Estimation of available energy of dietary fibres by indirect calorimetry in rats, Eur.J Nutr. 40, Seite 23-29.

Backstrom, J. R.; Lim, G. P.; Cullen, M. J. und Tokes, Z. A. (1996): Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40), J Neurosci. 16 [24], Seite 7910-7919.

Bado, A.; Roze, C.; Lewin, M. J. und Dubrasquet, M. (1989): Endogenous opioid peptides in the control of food intake in cats, Peptides 10 [5], Seite 967-971.

Bae, S. J.; Matsunaga, Y.; Takenaka, M.; Tanaka, Y.; Hamazaki, Y.; Shimizu, K. und Katayama, I. (2002): Substance P induced preprotachykinin-a mRNA, neutral endopeptidase mRNA and substance P in cultured normal fibroblasts, Int.Arch.Allergy Immunol. 127 [4], Seite 316-321.

Barker, P. E.; Shipp, M. A.; D'Adamio, L.; Masteller, E. L. und Reinherz, E. L. (1989): The common acute lymphoblastic leukemia antigen gene maps to chromosomal region 3 (q21-q27), J Immunol. 142 [1], Seite 283-287.

Barnes, K.; Matsas, R.; Hooper, N. M.; Turner, A. J. und Kenny, A. J. (1988): Endopeptidase-24.11 is striosomally ordered in pig brain and, in contrast to aminopeptidase N and peptidyl dipeptidase A ('angiotensin converting enzyme'), is a marker for a set of striatal efferent fibres, Neuroscience 27 [3], Seite 799-817.

Barnes, K.; Turner, A. J. und Kenny, A. J. (1993): An immunoelectron microscopic study of pig substantia nigra shows co-localization of endopeptidase-24.11 with substance P, Neuroscience 53 [4], Seite 1073-1082.

Barsh, G. S.; Farooqi, I. S. und O'Rahilly, S. (2000a): Genetics of body-weight regulation, Nature 404 [6778], Seite 644-651.

Beliaev, N. A.; Brusov, O. S. und Panchenko, L. F. (1983b): [Effect of chronic alcohol consumption on activity of enkephalinase A in rat striatum, hypothalamus and midbrain], Vopr.Med.Khim. 29 [1], Seite 102-107. URL: PM:6340337

Bergmann, KE und Mensink, GB (1999): Körpermaße und Übergewicht, Gesundheitswesen 61, Seite S115-S120.

Berman, Yemiliya; Mzhavia, Nino; Polonskaia, Ann und Devi, Lakshmi A. (2001): Impaired Prohormone Convertases in Cpefat/Cpefat Mice, Journal of Biological Chemistry 276 [2], Seite 1466-1473.

Beyreuther, Konrad (1999): Alzheimersche Krankheit - Molekulares Verständnis und therapeutische Implikationen, http://www.fes.de/fulltext/asfo/00234toc.htm.

Bitan, G.; Kirkitadze, M. D.; Lomakin, A.; Vollers, S. S.; Benedek, G. B. und Teplow, D. B. (2003): Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways, Proc.Natl.Acad.Sci.U.S.A 100 [1], Seite 330-335.

Bitan, Gal; Kirkitadze, Marina D.; Lomakin, Aleksey; Vollers, Sabrina S.; Benedek, George B. und Teplow, David B. (2003): Amyloid beta -protein (Abeta ) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways, Proceedings of the National Academy of Sciences 100 [1], Seite 330-335.

Blum, K.; Trachtenberg, M. C.; Elliott, C. E.; Dingler, M. L.; Sexton, R. L.; Samuels, A. I. und Cataldie, L. (1988): Enkephalinase inhibition and precursor amino acid loading improves inpatient treatment of alcohol and polydrug abusers: double-blind placebo-controlled study of the nutritional adjunct SAAVE, Alcohol 5 [6], Seite 481-493.

Bradford, M. M. (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal.Biochem 72, Seite 248-254.

Brady, K. T. und Sonne, S. C. (1999): The role of stress in alcohol use, alcoholism treatment, and relapse, Alcohol Res.Health 23 [4], Seite 263-271.

Brzyska, M.; Bacia, A. und Elbaum, D. (2001): Oxidative and hydrolytic properties of beta-amyloid, Eur.J Biochem 268 [12], Seite 3443-3454.

Bucciantini, M.; Giannoni, E.; Chiti, F.; Baroni, F.; Formigli, L.; Zurdo, J.; Taddei, N.; Ramponi, G.; Dobson, C. M. und Stefani, M. (2002): Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases, Nature 416 [6880], Seite 507-511.

Buenger, L.; Herrendoerfer, G. und Renne, U. (1990): Results of long term-selection for growth traits in laboratory mice., Proceedings of the 4th World Congress on Genetics Applied to Livestock Production 13, Seite 321-324.

Bundesministerium für Gesundheit und Soziale Sicherung (2000): Alkoholkonsum und alkoholbezogene Störungen in Deutschland, Schriftenreihe des BMG [128].

Bundesregierung (1996): Situation der Demenzkranken in der Bundesrepublik Deutschland, Deutscher Bundestag Drucksache 13/5257 13/5257.

Bush, A. I.; Pettingell, W. H.; Multhaup, G.; Paradis, M.; Vonsattel, J. P.; Gusella, J. F.; Beyreuther, K.; Masters, C. L. und Tanzi, R. E. (1994): Rapid induction of Alzheimer A beta amyloid formation by zinc, Science 265 [5177], Seite 1464-1467.

Carpentier, M.; Robitaille, Y.; DesGroseillers, L.; Boileau, G. und Marcinkiewicz, M. (2002): Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy, J Neuropathol.Exp Neurol. 61 [10], Seite 849-856.

Carson, J. A. und Turner, A. J. (2002): Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?, J Neurochem 81 [1], Seite 1-8.

Chen, H.; Charlat, O.; Tartaglia, L. A.; Woolf, E. A.; Weng, X.; Ellis, S. J.; Lakey, N. D.; Culpepper, J.; Moore, K. J.; Breitbart, R. E.; Duyk, G. M.; Tepper, R. I. und Morgenstern, J. P. (1996): Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice, Cell 84 [3], Seite 491-495.

Clarimon, J.; Munoz, F. J.; Boada, M.; Tarraga, L.; Sunyer, J.; Bertranpetit, J. und Comas, D. (2003): Possible increased risk for Alzheimer's disease associated with neprilysin gene, J Neural Transm. 110 [6], Seite 651-657.

Connelly, J. C.; Skidgel, R. A.; Schulz, W. W.; Johnson, A. R. und Erdos, E. G. (1985): Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide, Proc.Natl.Acad.Sci.U.S.A 82 [24], Seite 8737-8741.

Cowen, Michael S.; Chen, Feng und Lawrence, Andrew J. (2004): Neuropeptides: implications for alcoholism, Journal of Neurochemistry 89 [2], Seite 273-285.

Crabbe, J. C. (2002): Genetic contributions to addiction, Annu.Rev.Psychol. 53, Seite 435-462.

Crabbe, John C.; Wahlsten, Douglas und Dudek, Bruce C. (1999): Genetics of Mouse Behavior: Interactions with Laboratory Environment, Science 284 [5420], Seite 1670-1672.

Curtain, C. C.; Ali, F.; Volitakis, I.; Cherny, R. A.; Norton, R. S.; Beyreuther, K.; Barrow, C. J.; Masters, C. L.; Bush, A. I. und Barnham, K. J. (2001): Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits, J Biol Chem. 276 [23], Seite 20466-20473.

D'Adamio, L.; Shipp, M. A.; Masteller, E. L. und Reinherz, E. L. (1989): Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5' untranslated regions, Proc.Natl.Acad.Sci.U.S.A 86 [18], Seite 7103-7107.

d'Uscio, L. V.; Quaschning, T.; Burnett, J. C., Jr. und Luscher, T. F. (2001): Vasopeptidase Inhibition Prevents Endothelial Dysfunction of Resistance Arteries in Salt-Sensitive Hypertension in Comparison With Single ACE Inhibition, Hypertension 37 [1], Seite 28-33.

DeMattos, R. B.; Bales, K. R.; Cummins, D. J.; Paul, S. M. und Holtzman, D. M. (2002): Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease, Science 295 [5563], Seite 2264-2267.

Devault, A.; Lazure, C.; Nault, C.; Le Moual, H.; Seidah, N. G.; Chretien, M.; Kahn, P.; Powell, J.; Mallet, J.; Beaumont, A.; Roques, B. P.; Crine, P. und Boileau, G. (1987a): Amino acid sequence of rabbit kidney neutral endopeptidase 24.11 (enkephalinase) deduced from a complementary DNA, EMBO J 6 [5], Seite 1317-1322.

Dion, N.; Cohen, P.; Crine, P. und Boileau, G. (1997): Characterisation of neprilysin (EC 3.4.24.11) S2' subsite, FEBS Lett. 411 [1], Seite 140-144.

Duhl, D. M.; Vrieling, H.; Miller, K. A.; Wolff, G. L. und Barsh, G. S. (1994): Neomorphic agouti mutations in obese yellow mice, Nat Genet. 8 [1], Seite 59-65.

During, M. J.; Cao, L.; Zuzga, D. S.; Francis, J. S.; Fitzsimons, H. L.; Jiao, X.; Bland, R. J.; Klugmann, M.; Banks, W. A.; Drucker, D. J. und Haile, C. N. (2003a): Glucagon-like peptide-1 receptor is involved in learning and neuroprotection, Nat Med 9 [9], Seite 1173-1179.

Eckman, E. A.; Reed, D. K. und Eckman, C. B. (2001): Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme, J Biol Chem. 276 [27], Seite 24540-24548.

Engeli, S.; Schling, P.; Gorzelniak, K.; Boschmann, M.; Janke, J.; Ailhaud, G.; Teboul, M.; Massiera, F. und Sharma, A. M. (2003b): The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?, Int.J Biochem Cell Biol 35 [6], Seite 807-825.

Enoch, MA (2003): Pharmacogenomics of alcohol response and addiction, Am J Pharmacogenomics 3 [4], Seite 217-232.

Esteban, J. A. (2004): Living with the enemy: a physiological role for the beta-amyloid peptide, Trends Neurosci. 27 [1], Seite 1-3.

Farooqi, I. S.; Matarese, G.; Lord, G. M.; Keogh, J. M.; Lawrence, E.; Agwu, C.; Sanna, V.; Jebb, S. A.; Perna, F.; Fontana, S.; Lechler, R. I.; DePaoli, A. M. und O'Rahilly, S. (2002): Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency, J Clin Invest 110 [8], Seite 1093-1103.

Fezoui, Y.; Hartley, D. M.; Harper, J. D.; Khurana, R.; Walsh, D. M.; Condron, M. M.; Selkoe, D. J.; Lansbury, P. T.; Fink, A. L. und Teplow, D. B. (2000b): An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments, Amyloid 7 [3], Seite 166-178.

Findlay, G. S.; Wick, M. J.; Mascia, M. P.; Wallace, D.; Miller, G. W.; Harris, R. A. und Blednov, Y. A. (2002): Transgenic expression of a mutant glycine receptor decreases alcohol sensitivity of mice, J Pharmacol.Exp Ther. 300 [2], Seite 526-534.

Francis, R.; McGrath, G.; Zhang, J.; Ruddy, D. A.; Sym, M.; Apfeld, J.; Nicoll, M.; Maxwell, M.; Hai, B.; Ellis, M. C.; Parks, A. L.; Xu, W.; Li, J.; Gurney, M.; Myers, R. L.; Himes, C. S.; Hiebsch, R.; Ruble, C.; Nye, J. S. und Curtis, D. (2002): aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation, Dev Cell 3 [1], Seite 85-97.

Fraser, P. E.; Nguyen, J. T.; Inouye, H.; Surewicz, W. K.; Selkoe, D. J.; Podlisny, M. B. und Kirschner, D. A. (1992): Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein, Biochemistry 31 [44], Seite 10716-10723.

Frette, Catherine; Pezet, Sophie; El Nabout, Rita Azzi; Bertrand, Jean-Pierre; Pham, Quang Thieu; Kauffmann, Francine und Lafuma, Chantal (1998b): Relationship of serum neutral endopeptidase E.C.3.4.24.11 activity to alcohol consumption, Alcohol Clin Exp Res 22 [7], Seite 1405-1408.

Fricker, L. D.; Berman, Y. L.; Leiter, E. H. und Devi, L. A. (1996): Carboxypeptidase E activity is deficient in mice with the fat mutation. Effect on peptide processing, J Biol Chem. 271 [48], Seite 30619-30624.

Friedland, J. und Silverstein, E. (1976): A sensitive fluorimetric assay for serum angiotensin-converting enzyme, Am J Clin Pathol 66 [2], Seite 416-424.

Fulcher, I. S. und Kenny, A. J. (1983): Proteins of the kidney microvillar membrane. The amphipathic forms of endopeptidase purified from pig kidneys, Biochem J 211 [3], Seite 743-753.

GeneCards (2004): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=summary&list_uids=4311.

George, S. R.; Roldan, L.; Lui, A. und Naranjo, C. A. (1991): Endogenous opioids are involved in the genetically determined high preference for ethanol consumption, Alcohol Clin Exp Res 15 [4], Seite 668-672.

Gianoulakis, C. (2004): Endogenous opioids and addiction to alcohol and other drugs of abuse, Curr.Top.Med.Chem. 4 [1], Seite 39-50. URL: PM:14754375

Glenner, G. G. und Wong, C. W. (1984): Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem Biophys.Res Commun. 120 [3], Seite 885-890.

Gordon, H. W. (2002): Early environmental stress and biological vulnerability to drug abuse, Psychoneuroendocrinology 27 [1-2], Seite 115-126.

Grupp, L. A. (1992): Effects of angiotensin II and an angiotensin converting enzyme inhibitor on alcohol intake in P and NP rats, Pharmacol.Biochem Behav. 41 [1], Seite 105-108.

Grupp, L. A. und Chow, S. Y. (1992): Time-dependent effect of the angiotensin converting enzyme inhibitor, abutapril, on voluntary alcohol intake in the rat, Alcohol Alcohol 27 [3], Seite 267-271.

Gulpinar, M. A. und Yegen, B. C. (2004): The physiology of learning and memory: role of peptides and stress, Curr.Protein Pept.Sci. 5 [6], Seite 457-473.

Haemmerle, G.; Zimmermann, R.; Hayn, M.; Theussl, C.; Waeg, G.; Wagner, E.; Sattler, W.; Magin, T. M.; Wagner, E. F. und Zechner, R. (2002b): Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis, J Biol Chem. 277 [7], Seite 4806-4815.

Hama, E.; Shirotani, K.; Masumoto, H.; Sekine-Aizawa, Y.; Aizawa, H. und Saido, T. C. (2001): Clearance of extracellular and cell-associated amyloid beta peptide through viral expression of neprilysin in primary neurons, Journal of Biochemistry 130 [6], Seite 721-726.

Hardy, J. und Selkoe, D. J. (2002): The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science 297 [5580], Seite 353-356.

Heimann, A. S.; Favarato, M. H.; Gozzo, F. C.; Rioli, V.; Carreno, F. R.; Eberlin, M. N.; Ferro, E. S.; Krege, J. H. und Krieger, J. E. (2004): ACE gene titration in mice uncovers a new mechanism for ACE on the control of body weight, Physiol Genomics.

Helin, K.; Tikkanen, I.; Hohenthal, U. und Fyhrquist, F. (1994): Inhibition of either angiotensin-converting enzyme or neutral endopeptidase induces both enzymes, Eur.J Pharmacol. 264 [2], Seite 135-141.

Herpertz, S (2003): Psychotherapie der Adipositas, Dtsch Arztebl 100 [20], Seite A1367-A1373.

Hilbich, C.; Kisters-Woike, B.; Reed, J.; Masters, C. L. und Beyreuther, K. (1991): Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4, Eur.J Biochem 201 [1], Seite 61-69.

Hill, J. O.; Wyatt, H. R.; Reed, G. W. und Peters, J. C. (2003): Obesity and the environment: where do we go from here?, Science 299 [5608], Seite 853-855.

Hirsch, J.; Leibel, R. L. und Chua, S. C. (1992): A clinical perspective on peptides and food intake, Am J Clin Nutr. 55 [1 Suppl], Seite 296S-298S. URL: PM:1728843

Howell, S.; Nalbantoglu, J. und Crine, P. (1995): Neutral endopeptidase can hydrolyze beta-amyloid(1-40) but shows no effect on beta-amyloid precursor protein metabolism, Peptides 16 [4], Seite 647-652.

Hu, J.; Igarashi, A.; Kamata, M. und Nakagawa, H. (2001): Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity, J Biol Chem. 276 [51], Seite 47863-47868.

Huang, X.; Cuajungco, M. P.; Atwood, C. S.; Hartshorn, M. A.; Tyndall, J. D.; Hanson, G. R.; Stokes, K. C.; Leopold, M.; Multhaup, G.; Goldstein, L. E.; Scarpa, R. C.; Saunders, A. J.; Lim, J.; Moir, R. D.; Glabe, C.; Bowden, E. F.; Masters, C. L.; Fairlie, D. P.; Tanzi, R. E. und Bush, A. I. (1999): Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction, J Biol Chem. 274 [52], Seite 37111-37116.

Hulme, E. C. (1992): Receptor preparations for binding studies, Hulme, E. C., Receptor--Ligand Interactions, a Practical Approach , IRL Press.

Hupe-Sodmann, K.; Goke, R.; Goke, B.; Thole, H. H.; Zimmermann, B.; Voigt, K. und McGregor, G. P. (1997): Endoproteolysis of glucagon-like peptide (GLP)-1 (7-36) amide by ectopeptidases in RINm5F cells, Peptides 18 [5], Seite 625-632.

Hwang, B. H.; Stewart, R.; Zhang, J. K.; Lumeng, L. und Li, T. K. (2004): Corticotropin-releasing factor gene expression is down-regulated in the central nucleus of the amygdala of alcohol-preferring rats which exhibit high anxiety: a comparison between rat lines selectively bred for high and low alcohol preference, Brain Res 1026 [1], Seite 143-150.

Iwata, N.; Takaki, Y.; Fukami, S.; Tsubuki, S. und Saido, T. C. (2002): Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging, J Neurosci.Res 70 [3], Seite 493-500.

Iwata, N.; Tsubuki, S.; Takaki, Y.; Shirotani, K.; Lu, B.; Gerard, N. P.; Gerard, C.; Hama, E.; Lee, H. J. und Saido, T. C. (2001d): Metabolic regulation of brain Abeta by neprilysin, Science 292 [5521], Seite 1550-1552.

Iwata, N.; Tsubuki, S.; Takaki, Y.; Watanabe, K.; Sekiguchi, M.; Hosoki, E.; Kawashima-Morishima, M.; Lee, H. J.; Hama, E.; Sekine-Aizawa, Y. und Saido, T. C. (2000b): Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition, Nat Med. 6 [2], Seite 143-150.

Iwata, Nobuhisa; Higuchi, Makoto und Saido, Takaomi C. (2005a): Metabolism of amyloid beta peptide and Alzheimer's disease, Pharmacol.Thera. 108 [2], Seite 129-148.

Iwata, Nobuhisa; Mizukami, Hiroaki; Shirotani, Keiro; Takaki, Yoshie; Muramatsu, Shin ichi; Lu, Bao; Gerard, Norma P.; Gerard, Craig; Ozawa, Keiya und Saido, Takaomi C. (2004): Presynaptic Localization of Neprilysin Contributes to Efficient Clearance of Amyloid-{beta} Peptide in Mouse Brain, Journal of Neuroscience 24 [4], Seite 991-998.

Jacobowitz, David M.; Kresse, Adelheid und Skofitsch, Gerhard (2004): Galanin in the brain: chemoarchitectonics and brain cartography--a historical review*1, Peptides 25 [3], Seite 433-464.

Janek, K.; Rothemund, S.; Gast, K.; Beyermann, M.; Zipper, J.; Fabian, H.; Bienert, M. und Krause, E. (2001): Study of the conformational transition of A beta(1-42) using D-amino acid replacement analogues, Biochemistry 40 [18], Seite 5457-5463.

Jansen, S. (2004): Welt-Alzheimertag, Pharm.Ztg. 149 [38], Seite 46-46.

Johnstone, E. M.; Chaney, M. O.; Norris, F. H.; Pascual, R. und Little, S. P. (1991a): Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis, Brain Res Mol.Brain Res 10 [4], Seite 299-305.

Kenny, A. J. (1977): Proteinases associated with cell membranes, Barrett, A. J., Proteinases in Mammalian Cells and Tissues , Seite 393-444, Elsevier, Amsterdam.

Kenny, A. J. und Stephenson, S. L. (1988): Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide, FEBS Lett. 232 [1], Seite 1-8.

Kerr, M. A. und Kenny, A. J. (1974): The purification and specificity of a neutral endopeptidase from rabbit kidney brush border, Biochem J 137 [3], Seite 477-488.

Klaus, S.; Pultz, S.; Thone-Reineke, C. und Wolfram, S. (2005): Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation, Int.J Obesity 29, Seite 615-623.

Kleyn, P. W.; Fan, W.; Kovats, S. G.; Lee, J. J.; Pulido, J. C.; Wu, Y.; Berkemeier, L. R.; Misumi, D. J.; Holmgren, L.; Charlat, O.; Woolf, E. A.; Tayber, O.; Brody, T.; Shu, P.; Hawkins, F.; Kennedy, B.; Baldini, L.; Ebeling, C.; Alperin, G. D.; Deeds, J.; Lakey, N. D.; Culpepper, J.; Chen, H.; Glucksmann-Kuis, M. A.; Moore, K. J. und . (1996): Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family, Cell 85 [2], Seite 281-290.

Koolhaas, J. M.; De Boer, S. F.; De Rutter, A. J.; Meerlo, P. und Sgoifo, A. (1997): Social stress in rats and mice, Acta Physiol Scand.Suppl 640, Seite 69-72.

Kordik, C. P. und Reitz, A. B. (1999): Pharmacological treatment of obesity: therapeutic strategies, J Med Chem. 42 [2], Seite 181-201.

Kral, J. G. (2001): Morbidity of severe obesity, Surg.Clin North Am 81 [5], Seite 1039-1061.

Künast, Renate (2004): Plattform "Ernährung und Bewegung" - Gemeinsame Erklärung zwischen Bundesverbraucherministerium und der Lebensmittel-wirtschaft über die Errichtung einer gesamtgesellschaftlichen Plattform zur Förderung von Maßnahmen der Ernährungsaufklärung und der Steigerung der körperlichen Aktivität bei Kindern und Jugendlichen zur Prävention von Übergewicht., Pressemitteilung Nr.38 vom 11.Februar 2004. URL: http://www.verbraucherministerium.de/index-000C07D0943F102B8D2A6521C0A8D816.html

Kuo, Y. M.; Emmerling, M. R.; Vigo-Pelfrey, C.; Kasunic, T. C.; Kirkpatrick, J. B.; Murdoch, G. H.; Ball, M. J. und Roher, A. E. (1996): Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains, Journal of Biological Chemistry 271 [8], Seite 4077-4081.

Leibowitz, Sarah F. und Wortley, Katherine E. (2004): Hypothalamic control of energy balance: different peptides, different functions*1, Peptides 25 [3], Seite 473-504.

Leissring, M. A.; Farris, W.; Chang, A. Y.; Walsh, D. M.; Wu, X.; Sun, X.; Frosch, M. P. und Selkoe, D. J. (2003c): Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death, Neuron 40 [6], Seite 1087-1093.

Letarte, M.; Vera, S.; Tran, R.; Addis, J. B.; Onizuka, R. J.; Quackenbush, E. J.; Jongeneel, C. V. und McInnes, R. R. (1988): Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase, J Exp Med 168 [4], Seite 1247-1253.

Li, W.; Moore, M. J.; Vasilieva, N.; Sui, J.; Wong, S. K.; Berne, M. A.; Somasundaran, M.; Sullivan, J. L.; Luzuriaga, K.; Greenough, T. C.; Choe, H. und Farzan, M. (2003): Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature 426 [6965], Seite 450-454.

Liu, S. T.; Howlett, G. und Barrow, C. J. (1999): Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease, Biochemistry 38 [29], Seite 9373-9378.

Lu, B.; Gerard, N. P.; Kolakowski, L. F., Jr.; Bozza, M.; Zurakowski, D.; Finco, O.; Carroll, M. C. und Gerard, C. (1995): Neutral endopeptidase modulation of septic shock, J Exp Med 181 [6], Seite 2271-2275.

Lue, L. F.; Kuo, Y. M.; Roher, A. E.; Brachova, L.; Shen, Y.; Sue, L.; Beach, T.; Kurth, J. H.; Rydel, R. E. und Rogers, J. (1999): Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease, Am.J.Pathol. 155 [3], Seite 853-862.

Malfroy, B.; Kuang, W. J.; Seeburg, P. H.; Mason, A. J. und Schofield, P. R. (1988): Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase), FEBS Lett 229 [1], Seite 206-210.

Malfroy, B.; Schofield, P. R.; Kuang, W. J.; Seeburg, P. H.; Mason, A. J. und Henzel, W. J. (1987): Molecular cloning and amino acid sequence of rat enkephalinase, Biochem Biophys.Res Commun. 144 [1], Seite 59-66.

Malfroy, B.; Swerts, J. P.; Guyon, A.; Roques, B. P. und Schwartz, J. C. (1978b): High-affinity enkephalin-degrading peptidase in brain is increased after morphine, Nature 276 [5687], Seite 523-526.

Mann, D. M. (1988): The pathological association between Down syndrome and Alzheimer disease, Mech.Ageing Dev. 43 [2], Seite 99-136.

Marcic, B.; Deddish, P. A.; Jackman, H. L. und Erdos, E. G. (1999): Enhancement of bradykinin and resensitization of its B2 receptor, Hypertension 33 [3], Seite 835-843.

Marr, R. A.; Guan, H.; Rockenstein, E.; Kindy, M.; Gage, F. H.; Verma, I.; Masliah, E. und Hersh, L. B. (2004): Neprilysin regulates amyloid Beta peptide levels, J Mol.Neurosci. 22 [1-2], Seite 5-11.

Marr, Robert A.; Rockenstein, Edward; Mukherjee, Atish; Kindy, Mark S.; Hersh, Louis B.; Gage, Fred H.; Verma, Inder M. und Masliah, Eliezer (2003a): Neprilysin Gene Transfer Reduces Human Amyloid Pathology in Transgenic Mice, Journal of Neuroscience 23 [6], Seite 1992-1996.

Matsas, R.; Kenny, A. J. und Turner, A. J. (1984b): The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11, Biochem J 223 [2], Seite 433-440.

Maul, B.; Siems, W. E.; Hoehe, M. R.; Grecksch, G.; Bader, M. und Walther, T. (2001): Alcohol consumption is controlled by angiotensin II, FASEB J. 15 [9], Seite 1640-1642.

McDonald, J. K. (1986): Exopeptidases, Mammalian Proteases , Academic Press, London.

McLean, C. A.; Cherny, R. A.; Fraser, F. W.; Fuller, S. J.; Smith, M. J.; Beyreuther, K.; Bush, A. I. und Masters, C. L. (1999): Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease, Ann.Neurol. 46 [6], Seite 860-866.

Melzig, M. F. und Escher, F (2002a): Induction of neutral endopeptidase and angiotensin-converting enzyme activity of SK-N-SH cells in vitro by quercetin and resveratrol., Pharmazie 57 [8], Seite 556-558.

Melzig, M. F. und Janka, M (2003b): Enhancement of neutral endopeptidase activity in SK-N-SH cells by green tea extract., Phytomedicine 10 [6-7], Seite 494-498.

Melzig, M. F.; Papsdorf, G.; Putscher, I.; Winkler, A. und Siems, W. E. (1998): Inhibition of corticotropin releasing factor (CRF)-induced adrenocorticotropin (ACTH) secretion in pituitary corticotropic cells by substance P, Pharmazie 53 [8], Seite 569-572.

Menke, K. H. und Huss, W. (1980): Tierernährung und Futtermittelkunde., 2. Auflage. Auflage .

Messing, R. O. und Diamond, I (2001): Alcoholism, Encyclopedia of Life Sciences. URL: http://dx.doi.org/10.1038/npg.els.0003929

Miller, Bonnie C.; Eckman, Elizabeth A.; Sambamurti, Kumar; Dobbs, Nicole; Chow, K. Martin; Eckman, Christopher B.; Hersh, Louis B. und Thiele, Dwain L. (2003): Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo, Proceedings of the National Academy of Sciences 100 [10], Seite 6221-6226.

Mohajeri, M. H.; Wollmer, M. A. und Nitsch, R. M. (2002): Abeta 42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo, J Biol Chem. 277 [38], Seite 35460-35465.

Mokdad, A. H.; Bowman, B. A.; Ford, E. S.; Vinicor, F.; Marks, J. S. und Koplan, J. P. (2001): The continuing epidemics of obesity and diabetes in the United States, JAMA 286 [10], Seite 1195-1200.

Moller, C.; Sommer, W.; Thorsell, A.; Rimondini, R. und Heilig, M. (2002): Anxiogenic-like action of centrally administered glucagon-like peptide-1 in a punished drinking test, Prog.Neuropsychopharmacol.Biol Psychiatry 26 [1], Seite 119-122.

Morgan, D.; Grant, K. A.; Gage, H. D.; Mach, R. H.; Kaplan, J. R.; Prioleau, O.; Nader, S. H.; Buchheimer, N.; Ehrenkaufer, R. L. und Nader, M. A. (2002): Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration, Nat Neurosci 5 [2], Seite 169-174.

Mukherjee, A.; Song, E.; Kihiko-Ehmann, M.; Goodman, J. P., Jr.; Pyrek, J. S.; Estus, S. und Hersh, L. B. (2000): Insulysin hydrolyzes amyloid beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques, J Neurosci. 20 [23], Seite 8745-8749.

Mutschler, E.; Geisslinger, G.; Kroemer, H. K. und Schäfer-Korting, M. (2001): Arzneimittelwirkungen. Lehrbuch der Pharmakologie und Toxikologie., 8. Auflage , Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart.

Naggert, J. K.; Fricker, L. D.; Varlamov, O.; Nishina, P. M.; Rouille, Y.; Steiner, D. F.; Carroll, R. J.; Paigen, B. J. und Leiter, E. H. (1995a): Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity, Nat Genet. 10 [2], Seite 135-142.

National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1992): The genetics of alcoholism, Alcohol Alert 18. URL: http://pubs.niaaa.nih.gov/publications/aa18.htm

Nestler, E. J. (2001): Molecular basis of long-term plasticity underlying addiction, Nat Rev.Neurosci. 2 [2], Seite 119-128.

North, M. A. (1999): Advances in the molecular genetics of obesity., Curr.Opin.Genet.Dev. 9 [3], Seite 283-288.

O'Callaghan, J.; Croft, P. und Little, H. J. (2002): Effects of intraperitoneal injections of saline on the alcohol and sucrose consumption of C57/BL10 mice, Psychopharmacology (Berl) 160, Seite 206-212.

Oefner, C.; D'Arcy, A.; Hennig, M.; Winkler, F. K. und Dale, G. E. (2000b): Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon, J Mol.Biol 296 [2], Seite 341-349.

Olive, M. F.; Mehmert, K. K.; Koenig, H. N.; Camarini, R.; Kim, J. A.; Nannini, M. A.; Ou, C. J. und Hodge, C. W. (2003): A role for corticotropin releasing factor (CRF) in ethanol consumption, sensitivity, and reward as revealed by CRF-deficient mice, Psychopharmacology (Berl) 165 [2], Seite 181-187.

Olivecrona, T.; Chernick, S. S.; Bengtsson-Olivecrona, G.; Paterniti, J. R., Jr.; Brown, W. V. und Scow, R. O. (1985a): Combined lipase deficiency (cld/cld) in mice. Demonstration that an inactive form of lipoprotein lipase is synthesized, J Biol Chem. 260 [4], Seite 2552-2557.

Oliveri, Carla; Ocaranza, Maria Paz; Campos, Ximena; Lavandero, Sergio und Jalil, Jorge E. (2001): Angiotensin I-Converting Enzyme Modulates Neutral Endopeptidase Activity in the Rat, Hypertension 38 [3], Seite 650-654.

Opazo, C.; Huang, X.; Cherny, R. A.; Moir, R. D.; Roher, A. E.; White, A. R.; Cappai, R.; Masters, C. L.; Tanzi, R. E.; Inestrosa, N. C. und Bush, A. I. (2002b): Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2), J Biol Chem. 277 [43], Seite 40302-40308.

Ortlepp, J. R.; Breuer, J.; Eitner, F.; Kluge, K.; Kluge, R.; Floege, J.; Hollweg, G.; Hanrath, P. und Joost, H. G. (2002): Inhibition of the renin-angiotensin system ameliorates genetically determined hyperinsulinemia, Eur.J Pharmacol. 436 [1-2], Seite 145-150.

Otvos, L., Jr.; Szendrei, G. I.; Lee, V. M. und Mantsch, H. H. (1993): Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents, Eur.J Biochem 211 [1-2], Seite 249-257.

Padovani, A.; Pastorino, L.; Borroni, B.; Colciaghi, F.; Rozzini, L.; Monastero, R.; Perez, J.; Pettenati, C.; Mussi, M.; Parrinello, G.; Cottini, E.; Lenzi, G. L.; Trabucchi, M.; Cattabeni, F. und Di Luca, M. (2001): Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD, Neurology 57 [12], Seite 2243-2248.

Panchenko, L. F.; Brusov, O. S. und Beliaev, N. A. (1984b): [Mechanism of action of ethanol on enkephalinase A activity in the rat brain], Biull.Eksp.Biol Med. 97 [6], Seite 691-692.

Papandreou, C. N.; Usmani, B.; Geng, Y.; Bogenrieder, T.; Freeman, R.; Wilk, S.; Finstad, C. L.; Reuter, V. E.; Powell, C. T.; Scheinberg, D.; Magill, C.; Scher, H. I.; Albino, A. P. und Nanus, D. M. (1998): Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression, Nat Med. 4 [1], Seite 50-57.

Perry, T. A. und Greig, N. H. (2004): A new Alzheimer's disease interventive strategy: GLP-1, Curr.Drug Targets. 5 [6], Seite 565-571.

Perutz, M. F.; Finch, J. T.; Berriman, J. und Lesk, A. (2002): Amyloid fibers are water-filled nanotubes, Proc.Natl.Acad.Sci.U.S.A 99 [8], Seite 5591-5595.

Phillips, M. S.; Liu, Q.; Hammond, H. A.; Dugan, V.; Hey, P. J.; Caskey, C. J. und Hess, J. F. (1996): Leptin receptor missense mutation in the fatty Zucker rat, Nat.Genet. 13 [1], Seite 18-19.

Pitschke, M.; Prior, R.; Haupt, M. und Riesner, D. (1998): Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy, Nat Med. 4 [7], Seite 832-834.

Popov, N.; Pohle, W.; Lossner, B.; Schulzeck, S.; Schmidt, S.; Ott, T. und Matthies, H. (1973): Regional distribution of RNA and protein radioactivity in the rat brain after intraventricular application of labeled precursors, Acta Biol Med.Ger 31 [1], Seite 51-62.

Quay, T.; Slaughter, C.; Davis, T. P.; Merrill, B. J. und Hersh, L. B. (1994): Positional effects in the neprilysin (neutral endopeptidase) reaction, Arch.Biochem Biophys. 308 [1], Seite 133-136.

Rawlings, N. D. und Barrett, A. J. (1993): Evolutionary families of peptidases, Biochem J 290 ( Pt 1), Seite 205-218.

Redei, E.; Branch, B. J.; Gholami, S.; Lin, E. Y. und Taylor, A. N. (1988): Effects of ethanol on CRF release in vitro, Endocrinology 123 [6], Seite 2736-2743.

Richter, R. M.; Zorrilla, E. P.; Basso, A. M.; Koob, G. F. und Weiss, F. (2000a): Altered amygdalar CRF release and increased anxiety-like behavior in Sardinian alcohol-preferring rats: a microdialysis and behavioral study, Alcohol Clin Exp Res 24 [12], Seite 1765-1772.

Ritchie, J. C.; Davis, T. P. und Nemeroff, C. B. (2003a): Action of three ectopeptidases on corticotropin-releasing factor: metabolism and functional aspects, Neuropsychopharmacology 28 [1], Seite 22-33.

Rivier, C.; Bruhn, T. und Vale, W. (1984): Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF), J Pharmacol Exp Ther. 229 [1], Seite 127-131.

Riviere, P. J. und Bueno, L. (1987): Origin of the stimulation of food intake by oral administration of enkephalinase inhibitors in sheep, Life Sci. 41 [3], Seite 333-339.

Roach, M. K. und Creaven, P. J. (1968): A micro-method for the determination of acetaldehyde and ethanol in blood, Clin Chim.Acta 21 [2], Seite 275-278.

Robertson, J. M.; Harding, S. und Grupp, L. A. (1994): The reduction in alcohol intake produced by enalapril is not attenuated by centrally administered angiotensin inhibitors, Alcohol 11 [4], Seite 295-299.

Roher, Alex E.; Chaney, Michael O.; Kuo, Yu Min; Webster, Scott D.; Stine, W. Blaine; Haverkamp, Lanny J.; Woods, Amina S.; Cotter, Robert J.; Tuohy, James M.; Krafft, Grant A.; Bonnell, Barry S. und Emmerling, Mark R. (1996): Morphology and Toxicity of Abeta -(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease, Journal of Biological Chemistry 271 [34], Seite 20631-20635.

Roques, B. P.; Fournie-Zaluski, M. C.; Soroca, E.; Lecomte, J. M.; Malfroy, B.; Llorens, C. und Schwartz, J. C. (1980): The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice, Nature 288 [5788], Seite 286-288.

Roques, B. P.; Noble, F.; Dauge, V.; Fournie-Zaluski, M. C. und Beaumont, A. (1993): Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology, Pharmacol.Rev. 45 [1], Seite 87-146.

Rottkamp, C. A.; Atwood, C. S.; Joseph, J. A.; Nunomura, A.; Perry, G. und Smith, M. A. (2002): The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease, Peptides 23 [7], Seite 1333-1341.

Rouleau, J. L.; Pfeffer, M. A.; Stewart, D. J.; Isaac, D.; Sestier, F.; Kerut, E. K.; Porter, C. B.; Proulx, G.; Qian, C. und Block, A. J. (2000): Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial, Lancet 356 [9230], Seite 615-620.

Sahli, S.; Stump, B.; Welti, T.; Blum-Kaelin, D.; Aebi, J. D.; Oefner, C.; Bohm, H. J. und Diederich, F. (2004): Structure-based design, synthesis, and in vitro evaluation of nonpeptidic neprilysin inhibitors, Chembiochem. 5 [7], Seite 996-1000.

Saido, T. C. (2004): Aß (1-40) and (1-42) levels in plasma of NEP-KO and wildtype mice., Persönliche Mitteilung (Email).

Saito, Takashi; Iwata, Nobuhisa; Tsubuki, Satoshi; Takaki, Yoshie; Takano, Jiro; Huang, Shu Ming; Suemoto, Takahiro; Higuchi, Makoto und Saido, Takaomi C. (2005): Somatostatin regulates brain amyloid [beta] peptide A[beta]42 through modulation of proteolytic degradation, Nat Med 11 [4], Seite 434-439.

Sakai, A.; Ujike, H.; Nakata, K.; Takehisa, Y.; Imamura, T.; Uchida, N.; Kanzaki, A.; Yamamoto, M.; Fujisawa, Y.; Okumura, K. und Kuroda, S. (2004): Association of the Neprilysin gene with susceptibility to late-onset Alzheimer's disease, Dement.Geriatr.Cogn Disord. 17 [3], Seite 164-169. URL: PM:14739539

Sarnyai, Z.; Shaham, Y. und Heinrichs, S. C. (2001): The role of corticotropin-releasing factor in drug addiction, Pharmacol.Rev. 53 [2], Seite 209-243.

Schling, P. und Schäfer, T. (2002): Human adipose tissue cells keep tight control on the angiotensin II levels in their vicinity, J Biol Chem. 277 [50], Seite 48066-48075.

Schneider, R (1996): Relevanz und Kosten der Adipositas in Deutschland, Ernährungs-Umschau 43, Seite 369-374.

Schoeller, Olivia (2004b): Der schlankere Amerikaner, Berliner Zeitung, Seite 1-1.

Seidah, N. G.; Benjannet, S.; Hamelin, J.; Mamarbachi, A. M.; Basak, A.; Marcinkiewicz, J.; Mbikay, M.; Chretien, M. und Marcinkiewicz, M. (1999): The subtilisin/kexin family of precursor convertases. Emphasis on PC1, PC2/7B2, POMC and the novel enzyme SKI-1, Ann.N.Y.Acad.Sci. 885, Seite 57-74.

Selkoe, D. J. (2003): Folding proteins in fatal ways, Nature 426 [6968], Seite 900-904.

Selkoe, D. J. (2002): Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease, J Clin Invest 110 [10], Seite 1375-1381.

Selkoe, D. J. und Podlisny, M. B. (2002): Deciphering the genetic basis of Alzheimer's disease, Annu.Rev.Genomics Hum.Genet. 3, Seite 67-99.

Selkoe, D. J. und Schenk, D. (2003): Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics, Annu.Rev.Pharmacol.Toxicol. 43, Seite 545-584.

Sharma, Arya M. (2004): Is There a Rationale for Angiotensin Blockade in the Management of Obesity Hypertension?, Hypertension 44 [1], Seite 12-19.

Shipp, M. A.; Stefano, G. B.; Switzer, S. N.; Griffin, J. D. und Reinherz, E. L. (1991): CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation, Blood 78 [7], Seite 1834-1841.

Shirotani, K.; Tsubuki, S.; Iwata, N.; Takaki, Y.; Harigaya, W.; Maruyama, K.; Kiryu-Seo, S.; Kiyama, H.; Iwata, H.; Tomita, T.; Iwatsubo, T. und Saido, T. C. (2001b): Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases, J Biol Chem. 276 [24], Seite 21895-21901.

Shoghi-Jadid, K.; Small, G. W.; Agdeppa, E. D.; Kepe, V.; Ercoli, L. M.; Siddarth, P.; Read, S.; Satyamurthy, N.; Petric, A.; Huang, S. C. und Barrio, J. R. (2002): Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease, Am.J Geriatr.Psychiatry 10 [1], Seite 24-35.

Siems, W.; Maul, B.; Krause, W.; Gerard, C.; Hauser, K. F.; Hersh, L. B.; Fischer, H. S.; Zernig, G. und Saria, A. (2000h): Neutral endopeptidase and alcohol consumption, experiments in neutral endopeptidase-deficient mice, Eur.J.Pharmacol. 397 [2-3], Seite 327-334.

Siems, Wolf-Eberhard; Maul, Björn; Wiesner, Burkard; Becker, Matthias; Walther, Thomas; Rothe, L. und Winkler, Anett (2003): Effects of kinins on mammalian spermatozoa and the impact of peptidolytic enzymes, Andrologia 35 [1], Seite 44-54.

Sillaber, I.; Rammes, G.; Zimmermann, S.; Mahal, B.; Zieglgansberger, W.; Wurst, W.; Holsboer, F. und Spanagel, R. (2002b): Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors, Science 296 [5569], Seite 931-933.

Slawecki, C. J.; Jimenez-Vasquez, P.; Mathe, A. A. und Ehlers, C. L. (2001): Substance P and neurokinin levels are decreased in the cortex and hypothalamus of alcohol-preferring (P) rats, J.Stud.Alcohol 62 [6], Seite 736-740.

Soleilhac, J. M.; Lafuma, C.; Porcher, J. M.; Auburtin, G. und Roques, B. P. (1996a): Characterization of a soluble form of neutral endopeptidase-24.11 (EC 3.4.24.11) in human serum: enhancement of its activity in serum of underground miners exposed to coal dust particles, Eur.J.Clin.Invest 26 [11], Seite 1011-1017.

Solomon, C. G. und Manson, J. E. (1997): Obesity and mortality: a review of the epidemiologic data, Am J Clin Nutr. 66 [4 Suppl], Seite 1044S-1050S.

Steinmetz, A.; Fenselau, S. und Schrezenmeir, J. (2001): Treatment of dyslipoproteinemia in the metabolic syndrome, Exp Clin Endocrinol Diabetes 109 [4], Seite S548-S559.

Sturiale, S.; Barbara, G.; Qiu, B.; Figini, M.; Geppetti, P.; Gerard, N.; Gerard, C.; Grady, E. F.; Bunnett, N. W. und Collins, S. M. (1999): Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P, Proc.Natl.Acad.Sci.U.S.A 96 [20], Seite 11653-11658.

Szczepanska, R. und Grupp, L. A. (1993): Bestatin, an aminopeptidase B inhibitor, selectively reduces alcohol intake in rats, Alcohol Clin Exp Res 17 [2], Seite 434-437.

Szczepanska, R.; Harding, S. und Grupp, L. A. (1996): Effect of bestatin, an aminopeptidase inhibitor, on alcohol intake in alcohol-preferring P rats, Alcohol Clin Exp Res 20 [3], Seite 561-565.

Takaki, Y.; Iwata, N.; Tsubuki, S.; Taniguchi, S.; Toyoshima, S.; Lu, B.; Gerard, N. P.; Gerard, C.; Lee, H. J.; Shirotani, K. und Saido, T. C. (2000a): Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amyloid beta peptide in the brain, Journal of Biochemistry 128 [6], Seite 897-902.

Tam, L. T.; Engelbrecht, S.; Talent, J. M.; Gracy, R. W. und Erdos, E. G. (1985): The importance of disulfide bridges in human endopeptidase (enkephalinase) after proteolytic cleavage, Biochem Biophys.Res Commun. 133 [3], Seite 1187-1192.

The Protein Data Bank (2004): 1DMT, http://www.rcsb.org/pdb/cgi/explore.cgi?pid=94401132867010&pdbId=1DMT.

Thiele, Todd E.; Navarro, Montserrat; Sparta, Dennis R.; Fee, Jon R.; Knapp, Darin J. und Cubero, Inmaculada (2003): Alcoholism and obesity: overlapping neuropeptide pathways?, Neuropeptides 37 [6], Seite 321-337.

Timpl, P.; Spanagel, R.; Sillaber, I.; Kresse, A.; Reul, J. M.; Stalla, G. K.; Blanquet, V.; Steckler, T.; Holsboer, F. und Wurst, W. (1998): Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1, Nat Genet. 19 [2], Seite 162-166.

Toyoda, M.; Nakamura, M.; Makino, T.; Kagoura, M. und Morohashi, M. (2002): Sebaceous glands in acne patients express high levels of neutral endopeptidase, Exp Dermatol. 11 [3], Seite 241-247.

Tsubuki, S.; Takaki, Y. und Saido, T. C. (2003): Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Abeta to physiologically relevant proteolytic degradation, Lancet 361 [9373], Seite 1957-1958.

Turner, A. J. (2003): Exploring the structure and function of zinc metallopeptidases: old enzymes and new discoveries, Biochem Soc Trans 31 [Pt 3], Seite 723-727.

Turner, A. J. (1998): Neprilysin, Barrett, A. J.; Rawlings, N. D. und Woessner, j. f., Handbook of proteolytic enzymes , Seite 1080-1085, Academic Press, San Diego.

Vassar, R. und Citron, M. (2000): Abeta-generating enzymes: recent advances in beta- and gamma-secretase research, Neuron 27 [3], Seite 419-422.

Vaughan, D. W. und Peters, A. (1981): The structure of neuritic plaque in the cerebral cortex of aged rats, J Neuropathol.Exp Neurol. 40 [4], Seite 472-487.

Vekrellis, Konstantinos; Ye, Zhen; Qiu, Wei Qiao; Walsh, Dominic; Hartley, Dean; Chesneau, Valerie; Rosner, Marsha Rich und Selkoe, Dennis J. (2000): Neurons Regulate Extracellular Levels of Amyloid beta -Protein via Proteolysis by Insulin-Degrading Enzyme, Journal of Neuroscience 20 [5], Seite 1657-1665.

Waksman, G.; Hamel, E.; Fournie-Zaluski, M. C. und Roques, B. P. (1986): Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of mu and delta opioid receptors in rat brain, Proc.Natl.Acad.Sci.U.S.A 83 [5], Seite 1523-1527.

Wallenius, Ville; Wallenius, Kristina; Ahrén, Bo; Rudling, Mats; Carlsten, Hans; Dickson, Suzanne L.; Ohlsson, Claes und Jansson, John-Olov (2005): Interleukin-6-deficient mice develop mature-onset obesity, Nature Medicine 8, Seite 75-79.

Walsh, D. M.; Klyubin, I.; Fadeeva, J. V.; Cullen, W. K.; Anwyl, R.; Wolfe, M. S.; Rowan, M. J. und Selkoe, D. J. (2002): Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo, Nature 416 [6880], Seite 535-539.

Walther, T.; Albrecht, D.; Becker, A.; Becker, M.; Schubert, M.; Maul, B.; Stoltenburg, G.; Schultheiss, H. P.; Grecksch, G. und Siems, W. E. (2005): Janus-head neutral endopeptidase (NEP) - Improved learning and memory in old-aged mice that are deficient in the amyloid-ß-degrading peptidase NEP., In Vorbereitung.

Walther, T.; Stepan, H.; Pankow, K.; Becker, M.; Schultheiss, H. P. und Siems, W. E. (2004): Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide, Biol.Chem. 385 [2], Seite 179-184.

Wengenack, T. M.; Curran, G. L. und Poduslo, J. F. (2000): Targeting alzheimer amyloid plaques in vivo, Nat Biotechnol. 18 [8], Seite 868-872.

Wick, M. J.; Mihic, S. J.; Ueno, S.; Mascia, M. P.; Trudell, J. R.; Brozowski, S. J.; Ye, Q.; Harrison, N. L. und Harris, R. A. (1998): Mutations of gamma-aminobutyric acid and glycine receptors change alcohol cutoff: evidence for an alcohol receptor?, Proc.Natl.Acad.Sci.U.S.A 95 [11], Seite 6504-6509.

Winkler, Anett; Rottmann, Matthias; Heder, Gottfried; Hyytiä, Petri; Siems, Wolf-Eberhard und Melzig, Matthias F. (1998b): Gene expression and activity of specific opioid-degrading enzymes in different brain regions of the AA and ANA lines of rats, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1406 [3], Seite 219-227.

Wong-Leung, Y. L. und Kenny, A. J. (1968): Some properties of a microsomal peptidase in rat kidney, Biochem J 110 [2], Seite 5P.

Yamaguchi, T.; Fukase, M.; Arao, M.; Sugimoto, T. und Chihara, K. (1992): Endothelin 1 hydrolysis by rat kidney membranes, FEBS Lett. 309 [3], Seite 303-306.

Yang, D. S.; McLaurin, J.; Qin, K.; Westaway, D. und Fraser, P. E. (2000): Examining the zinc binding site of the amyloid-beta peptide, Eur.J Biochem 267 [22], Seite 6692-6698.

Yasojima, K.; Akiyama, H.; McGeer, E. G. und McGeer, P. L. (2001): Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide, Neurosci.Lett. 297 [2], Seite 97-100.

Yasojima, K.; McGeer, E. G. und McGeer, P. L. (2001): Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain, Brain Res 919 [1], Seite 115-121.

Yu, G.; Nishimura, M.; Arawaka, S.; Levitan, D.; Zhang, L.; Tandon, A.; Song, Y. Q.; Rogaeva, E.; Chen, F.; Kawarai, T.; Supala, A.; Levesque, L.; Yu, H.; Yang, D. S.; Holmes, E.; Milman, P.; Liang, Y.; Zhang, D. M.; Xu, D. H.; Sato, C.; Rogaev, E.; Smith, M.; Janus, C.; Zhang, Y.; Aebersold, R.; Farrer, L. S.; Sorbi, S.; Bruni, A.; Fraser, P. und George-Hyslop, P. (2000): Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing, Nature 407 [6800], Seite 48-54.

Zhang, Y.; Proenca, R.; Maffei, M.; Barone, M.; Leopold, L. und Friedman, J. M. (1994): Positional cloning of the mouse obese gene and its human homologue, Nature 372 [6505], Seite 425-432.

Zhu, X.; Zhou, A.; Dey, A.; Norrbom, C.; Carroll, R.; Zhang, C.; Laurent, V.; Lindberg, I.; Ugleholdt, R.; Holst, J. J. und Steiner, D. F. (2002): Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects, Proc.Natl.Acad.Sci.U.S.A 99 [16], Seite 10293-10298.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
24.11.2006